Advisorshares Trust · net assets $44.4M · 32 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 93.1% · STIV: 6.9%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $9.15M | $1.22M | $4.08M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $0 | $0 | $0 |
| Net realized gain (non-derivative) | $-85.1K | $-144K | $429K |
| Net unrealized appreciation (non-derivative) | $3.41M | $2.92M | $3.24M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Definium Therapeutics Inc EC | $5.71M | 12.85% |
| Compass Pathways PLC EC | $5.09M | 11.45% |
| Ataibeckley Inc EC | $4.65M | 10.47% |
| Relmada Therapeutics Inc EC | $3.04M | 6.84% |
| Nrx Pharmaceuticals Inc EC | $2.7M | 6.07% |
| Neurocrine Biosciences Inc EC | $1.95M | 4.38% |
| Cybin Inc EC | $1.93M | 4.35% |
| Gh Research PLC EC | $1.92M | 4.31% |
| Alkermes PLC EC | $1.91M | 4.30% |
| Alto Neuroscience Inc EC | $1.87M | 4.20% |
| Abbvie Inc EC | $1.84M | 4.14% |
| Blackrock Treasury Trust STIV | $1.76M | 3.97% |
| Bright Minds Biosciences Inc EC | $1.7M | 3.84% |
| Johnson & Johnson EC | $1.6M | 3.61% |
| Drey Inst Pref Gov Mm-m STIV | $1.38M | 3.10% |
| Supernus Pharmaceuticals Inc EC | $1.28M | 2.89% |
| Neuphoria Therapeutics Inc EC | $1.11M | 2.49% |
| Neuronetics Inc EC | $966K | 2.17% |
| Quantum Biopharma Ltd EC | $737K | 1.66% |
| Optimi Health Corp EC | $523K | 1.18% |
| Pasithea Therapeutics Corp EC | $483K | 1.09% |
| Silo Pharma Inc EC | $469K | 1.06% |
| Psyence Biomedical Ltd EC | $374K | 0.84% |
| Incannex Healthcare Inc EC | $229K | 0.52% |
| Numinus Wellness Inc EC | $209K | 0.47% |
| Igc Pharma Inc EC | $185K | 0.42% |
| Vistagen Therapeutics Inc EC | $99.1K | 0.22% |
| Enveric Biosciences Inc EC | $48.9K | 0.11% |
| Clearmind Medicine Inc EC | $2.57K | 0.01% |
| Quantum Biopharma EC | — | 0.00% |
| Sage Therapeutics Inc EC | — | 0.00% |
| Unbuzzd Wellness Inc EC | — | 0.00% |
Loading...
